ZNF260 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.925980E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.140420E-01
Normal-vs-Stage2
2.011000E-01
Normal-vs-Stage3
1.338710E-03
Normal-vs-Stage4
9.953800E-01
Stage1-vs-Stage2
8.160600E-01
Stage1-vs-Stage3
2.157700E-02
Stage1-vs-Stage4
3.326400E-01
Stage2-vs-Stage3
1.100200E-01
Stage2-vs-Stage4
1.506190E-01
Stage3-vs-Stage4
1.197820E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.793620E-01
Normal-vs-AfricanAmerican
1.692810E-01
Normal-vs-Asian
3.600400E-01
Caucasian-vs-AfricanAmerican
9.923400E-01
Caucasian-vs-Asian
8.750200E-01
AfricanAmerican-vs-Asian
9.382000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.484000E-01
Normal-vs-Female
2.679600E-01
Male-vs-Female
3.485600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.124000E-01
Normal-vs-Age(41-60Yrs)
5.609400E-01
Normal-vs-Age(61-80Yrs)
8.621800E-02
Normal-vs-Age(81-100Yrs)
4.900400E-03
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.898600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
2.507400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.097900E-02
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.060400E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.676290E-03
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.401000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.630200E-01
Normal-vs-Daily Drinker
1.242430E-02
Normal-vs-Weekly Drinker
4.844200E-02
Normal-vs-Occasional Drinker
4.180000E-01
Normal-vs-Social Drinker
3.387600E-01
Non Drinker-vs-Daily Drinker
3.716000E-01
Non Drinker-vs-Weekly Drinker
7.409000E-01
Non Drinker-vs-Occasional Drinker
2.338000E-01
Non Drinker-vs-Social Drinker
4.443600E-01
Daily Drinker-vs-Weekly Drinker
6.037800E-01
Daily Drinker-vs-Occasional Drinker
1.115880E-02
Daily Drinker-vs-Social Drinker
5.322500E-02
Weekly Drinker-vs-Occasional Drinker
8.144300E-02
Weekly Drinker-vs-Social Drinker
2.121600E-01
Occasional Drinker-vs-Social Drinker
7.008600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
5.329500E-02
Normal-vs-Grade 2
1.726240E-02
Normal-vs-Grade 3
3.848000E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.084600E-01
Grade 1-vs-Grade 3
1.424030E-01
Grade 1-vs-Grade 4
5.329500E-02
Grade 2-vs-Grade 3
1.976040E-01
Grade 2-vs-Grade 4
1.726240E-02
Grade 3-vs-Grade 4
3.848000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.707700E-02
Normal-vs-NonDiabetic
2.237400E-01
Diabetic-vs-NonDiabetic
2.106800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.146200E-02
Normal-vs-NoPancreatitis
1.966160E-01
Pancreatitis-vs-NoPancreatitis
5.508600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.493630E-01
Normal-vs-N1
2.177400E-01
N0-vs-N1
6.409400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.904400E-01
Normal-vs-TP53-NonMutant
1.460770E-01
TP53-Mutant-vs-TP53-NonMutant
9.444800E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
